Enter
Enter
Alere ii Influenza
Influenza A&B
A&B
Alere
TM
TM
Molecular results in less than 15 minutes
Molecular results in less than 15 minutes
Transforming near-patient testing
Unique isothermal amplification technology giving you molecular
results, faster than ever before
Unique
Technology
Improving patient outcomes
Giving you the confidence to make effective clinical decisions sooner
Faster
Results
Outstanding
Performance
Optimizing operational efficiency
• Enables prompt initiation of infection control measures
• Connected results direct to your network
• Facilitating effective patient management
Enabling effective Antimicrobial Stewardship
Molecular sensitivity in an actionable timeframe allows the prudent use of antibiotics and antivirals
Intuitive
Design
Antimicrobial
Stewardship
Ordering
Information
Alere i
Influenza A&B
TM
A positive impact on your facility
Reliable near-patient testing reduces overall healthcare costs4
Confidence at the point of care
Intuitive and reliable, allowing you to respond quickly and accurately in any setting
Alere i utilizes unique isothermal nucleic acid amplification
technology which does not require temperature cycling or a
sample purification step
TM
Unique
Technology
Faster
Results
Extraction
Reverse Transcription
Amplification
Detection
Result
Test Results
DD/MM/YY
Tes
t R es ults
Outstanding
Performance
Patient: 10axj940
DD/MM/Y
Y Alereuser1
User ID:
P atient: 10axj940
Us er ID: Alereus er1
A: Negative
FluFlu
A: Negative
11:22 am
P rocedural
C ontrol Valid
11:22 am
Procedural
Control Valid
Flu B: Positive
Flu B: Positive
New Tes t
New Test
P rint
Print
Intuitive
Design
0 min
Antimicrobial
Stewardship
Ordering
Information
Alere i
Influenza A&B
TM
<15 min
Alere i is significantly faster than other molecular methods
and more accurate than conventional rapid testing giving you
the confidence to make effective patient management
decisions sooner
TM
Unique
Technology
Faster
Results
Modern Molecular System
Outstanding
Performance
Conventional Real-Time PCR
Viral Culture
Intuitive
Design
Antimicrobial
Stewardship
Ordering
Information
Alere i
Influenza A&B
TM
0m
15m
30m
45m
1h
2h
3h
4h
12h
24h
“Alere i demonstrates impressive sensitivity for the detection of
both influenza A and B in clinical respiratory specimens obtained
from children and adults” 3
TM
Unique
Technology
Alere i Influenza A & B Performance vs. Culture1
TM
Sensitivity
Faster
Results
Influenza A
Outstanding
Performance
Intuitive
Design
Influenza B
Specificity
97.9%
86.2%
(95% CI: 92.6%, 99.4%)
(95% CI: 82.8%, 89.0%)
92.5%
96.5%
(95% CI: 84.6%, 96.5%)
(95% CI: 94.5%, 97.8%)
Alere i Influenza A & B Performance vs. Culture1
Discrepant result resolved by RT-PCR
TM
Antimicrobial
Stewardship
Sensitivity
Influenza A
Ordering
Information
Influenza B
Specificity
99.3%
98.1%
(95% CI: 96.3%, 99.9%)
(95% CI: 96.3%, 99.9%)
97.8%
99.6%
(95% CI: 92.3%, 99.4%)
(95% CI: 98.5%, 99.9%)
*All specimens generating discrepant results between the Alere i Influenza A & B test and viral culture were tested using an
FDA cleared RT-PCR assay to confirm influenza status. Performance of Alere i Influenza A & B when the results of PCR on
discrepant samples are incorporated is presented in the table above.
TM
TM
Alere i
Influenza A&B
TM
“A simple and easy to use molecular diagnostic test”2
Sample type nasal swab
Unique
Technology
Visual touchscreen no need
for separate instructions
Easy to use requires only
minimal training
Small footprint can be used
in any healthcare setting
Streamlined workflow
connectivity can be provided
to your network
Faster
Results
145 mm / 5.71”
Outstanding
Performance
Intuitive
Design
Antimicrobial
Stewardship
Ordering
Information
Alere i
Influenza A&B
”
Test Base
Sample Receiver
Transfer Cartridge
207 mm
4
/ 8.15”
TM
Simple
Easy to Use
In Any Setting
19
mm
/
4
7.6
Easy to use with a simple touch screen
Home
Unique
Technology
Faster
Results
6/Feb/2014 12:00pm
Run
Test
Run QC
Test
Review
Memory
Preferences
Setup
Log Out
Outstanding
Performance
Intuitive
Design
Antimicrobial
Stewardship
Run Test
Test Results
Remove seal.
Mix swab for
10 seconds and
discard the swab
DD/MM/YY
Patient: 10axj940
User ID: Alereuser1
(6:37)
Flu B: Positive
Ordering
Information
Alere i
Influenza A&B
Step 4 of 6
11:22 am
Procedural
Control Valid
Flu A: Negative
New Test
Print
TM
Simple
Easy to Use
In Any Setting
Suitable for use in any healthcare setting
Unique
Technology
Faster
Results
Outstanding
Performance
Intuitive
Design
Antimicrobial
Stewardship
Emergency Department
Laboratory
Physician's Office
Ordering
Information
Alere™ i products are Moderately Complex.
Alere i
Influenza A&B
TM
Simple
Easy to Use
In Any Setting
Unique
Technology
Faster
Results
Outstanding
Performance
Intuitive
Design
Antimicrobial
Stewardship
Ordering
Information
Alere i
Influenza A&B
TM
The Test Target Treat antimicrobial
stewardship initiative from Alere empowers
you to make targeted treatment decisions
sooner with rapid diagnostics; reducing the
inappropriate use of antibiotics and antivirals,
and the spread of resistance.
TM
Find out more at TestTargetTreat.com
Visit
Alere-i.com today
or contact us: [email protected]
Unique
Technology
Faster
Results
Outstanding
Performance
23046617
23046618
23046619
Alere i Instrument
Alere i Influenza A & B 24 Test Kit, CPT: 87502
Alere i Influenza A & B Control Swab Kit
Alere i Barcode Scanner
Alere Universal Printer
™
™
™
EQ001001
55115
™
™
References:
Intuitive
Design
1. Alere i Influenza A & B Package Insert.
2. Bell, J. and Selvarangan, R. Evaluation of the Rapid Alere i Influenza A & B Nucleic Acid Amplification Test Using Respiratory Specimens Collected
in Viral Transport Medium. Poster presented at Clinical Virology Symposium. (2013) Children’s Mercy Hospitals and Clinics, and University of Missouri,
Kansas City School of Medicine, Kansas City, MO
3. Bell, J. et al. (2013) Clinical Evaluation of the Alere i Influenza A & B Assay, a Point-of-Care Rapid Nucleic Acid Amplification Test for Detection of
Influenza. Children’s Mercy Hospitals and Clinics and University of Missouri Kansas City School of Medicine, Kansas City, MO. Veritas, P.A., Belton,
TX. Nationwide Children’s Hospital, Columbus, OH. New York Methodist Hospital, Brooklyn, NY. Ann & Robert Lurie Children’s Hospital of Chicago
and Northwestern University Feinberg School of Medicine, Chicago, IL. Albany Medical College, Albany, NY. Wake Forest University Baptist Medical
Center, Winston-Salem, NC.
4. Bonner, A.B. et al. (2003) Impact of the Rapid Diagnosis of Influenza on Physician Decision-Making and Patient Management in the Pediatric
Emergency Department: Results of a Randomized, Prospective, Controlled Trial. Pediatrics Vol. 112 No. 2.
™
™
™
Antimicrobial
Stewardship
Ordering
Information
Alere i
Influenza A&B
TM
© 2014 Alere. All rights reserved. The Alere Logo, Alere, Molecular. In minutes. and Test Target Treat are trademarks of the Alere group.
The Fisher Healthcare Logo is a trademark of Fisher Scientific Company, L.L.C. 120001474E-01 09/14
For Customer Service, call 1-800-640-0640
To fax an order, use 1-800-290-0290
To order online: www.fisherhealthcare.com